Saunders P T, Majdic G, Parte P, Millar M R, Fisher J S, Turner K J, Sharpe R M
MRC Reproductive Biology Unit, Edinburgh, Scotland.
Adv Exp Med Biol. 1997;424:99-110. doi: 10.1007/978-1-4615-5913-9_19.
The incidence of reproductive abnormalities in the male has been reported to have increased during the past 50 years. It has been suggested that these changes may be attributable to the presence of chemicals with oestrogenic activity in our environment. The aim of the experiments described in this chapter was to investigate the effects of acute exposure to high levels of xenoestrogens either indirectly during fetal life, or directly during neonatal life, on gene expression in the testis and pituitary. Fetal treatment involved administration of diethylstilbestrol (DES), 4-octylphenol (OP) or vehicle (oil, control) to pregnant rats on days 11.5 and 15.5 post coitum; fetuses were recovered on day 17.5. There was no difference between fetuses from control and treated mothers in either the overall histology of the testes or numbers of Leydig cells as determined by immunohistochemistry with an antibody directed against 3 beta-HSD. However there was a consistent and striking reduction in the amount of P450 17-a hydroxylase C17, 20 lyase (P450c17) and steroidogenic factor 1 (SF-1) detected by immunocytochemistry in testes from treatment groups given the higher doses of OP and DES. Oestrogen receptors (ER alpha) were present in the fetal leydig cells of all animals. Neonatal treatment involved direct injection of oil (control), DES, OP or Bisphenol A (Bis A) on days 2, 4, 6, 8, 10 and 12; pituitaries and testes were recovered on day 18. Testis weights and seminiferous tubule diameters were significantly reduced in animals treated with DES. In these same animals immunocytochemical localisation revealed that the amounts of FSH beta subunit and inhibin alpha subunit were reduced in their pituitaries and testes respectively. OP did not appear to have an acute, measurable effect on testis gene expression but a reduction in testis weight was noted in adult animals given the same treatment regime. The effects observed are consistent with negative feedback by oestrogens on pituitary production of FSH resulting in retarded maturation of seminiferous tubules and reduced Sertoli cell numbers. These studies have demonstrated that administration of high levels of oestrogens can affect gene expression in the testis early in life. However, the relevance of these findings to observations in man await a) a greater understanding of the physiological role(s) of oestrogens in normal males, b) an evaluation of the sources, routes of exposure, concentrations in vivo and bioavailability of xenoestrogens.
据报道,在过去50年中男性生殖异常的发生率有所上升。有人认为,这些变化可能归因于我们环境中存在具有雌激素活性的化学物质。本章所述实验的目的是研究在胎儿期间接或在新生儿期直接急性暴露于高剂量外源性雌激素对睾丸和垂体基因表达的影响。胎儿处理包括在妊娠第11.5天和15.5天给怀孕大鼠注射己烯雌酚(DES)、4-辛基酚(OP)或赋形剂(油,对照);在第17.5天取出胎儿。通过用针对3β-羟类固醇脱氢酶的抗体进行免疫组织化学测定,对照和处理组母亲的胎儿在睾丸的整体组织学或Leydig细胞数量上没有差异。然而,在给予较高剂量OP和DES的处理组的睾丸中,通过免疫细胞化学检测到的P450 17-α羟化酶C17,20裂解酶(P450c17)和类固醇生成因子1(SF-1)的量持续且显著减少。所有动物的胎儿Leydig细胞中均存在雌激素受体(ERα)。新生儿处理包括在第2、4、6、8、10和12天直接注射油(对照)、DES、OP或双酚A(Bis A);在第18天取出垂体和睾丸。用DES处理的动物睾丸重量和生精小管直径显著降低。在这些相同的动物中,免疫细胞化学定位显示,垂体和睾丸中FSHβ亚基和抑制素α亚基的量分别减少。OP似乎对睾丸基因表达没有急性可测量的影响,但在给予相同处理方案的成年动物中注意到睾丸重量降低。观察到的这些影响与雌激素对垂体FSH产生的负反馈一致,导致生精小管成熟延迟和支持细胞数量减少。这些研究表明,高剂量雌激素的给药可在生命早期影响睾丸中的基因表达。然而,这些发现与人类观察结果的相关性有待于:a)更深入了解雌激素在正常男性中的生理作用,b)评估外源性雌激素的来源、暴露途径、体内浓度和生物利用度。